21 citations
,
  July 2011   in “Journal of the American Academy of Dermatology”    A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.  
     
           18 citations
,
  January 2017   in “Postępy Dermatologii i Alergologii”    EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.  
     
           November 2022   in “The journal of investigative dermatology/Journal of investigative dermatology”    Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.  
               26 citations
,
  September 2012   in “Cell Reports”    B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.  
               6 citations
,
  December 2019   in “Frontiers in genetics”    GLI1 might protect against the start of skin cancer and is not linked to cancer severity.